SCHEMBL6969608

SCHEMBL6969608

O=C(O)CCCc1cc[nH]c(=O)c1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.43
F13A1 P00488 3/20 0.38
HDAC3 O15379 1/20 0.37
MAPK1 P28482 1/20 0.37
ADRA1A P35348 1/20 0.37
HDAC4 P56524 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HDAC1 Q13547 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
THRB P10828 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7234126 0.82 CYP1A2 (0.43) PARP1L3MBTL1THRBHPGDMEN1
SCHEMBL6975291 0.78 F13A1 (0.36) F13A1SMN1; SMN2L3MBTL1THRBHPGD
SCHEMBL22614890 0.74 GPR35 (0.47) HDAC3MAPK1ADRA1AHDAC4SLC6A3
SCHEMBL15173464 0.73 ALDH1A1 (0.42) MEN1KMT2AALDH1A1
SCHEMBL29610691 0.72 FBP1 (0.41) F13A1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL4659158 0.72 CYSLTR2 (0.46) HDAC3MAPK1ADRA1AHDAC4SLC6A3
SCHEMBL7820610 0.71 CYP1A2 (0.50) F13A1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL2492917 0.71 ALDH1A1 (0.41) F13A1HDAC3MAPK1ADRA1AHDAC4
SCHEMBL4656911 0.69 CYSLTR2 (0.43) HDAC3MAPK1ADRA1AHDAC4SLC6A3
SCHEMBL4657892 0.69 ALDH1A1 (0.53) HDAC3MAPK1ADRA1AHDAC4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1272487-A1 BICYCLIC HETEROARYL COMPOUNDS AS INHIBITORS OF THE INTERACTION BETWEEN THE INTEGRIN ALPHA4BETA1 RECEPTOR AND VCAM-1 AND/OR FIBRONECTIN AstraZeneca AB (SE) 2003-01-08 EP disclosed
WO-2001053295-A1 BICYCLIC HETEROARYL COMPOUNDS AS INHIBITORS OF THE INTERACTION BETWEEN THE INTEGRIN ALPHA4BETA1 RECEPTOR AND VCAM-1 AND/OR FIBRONECTIN ASTRAZENECA AB (SE) 2001-07-26 WO disclosed